コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 as a preliminary screen for the presence of bovine tuberculosis.
2 tional exposure to an index case of human or bovine tuberculosis.
3 ase elimination due to the chronic nature of bovine tuberculosis.
4 -studied wildlife systems such as rabies and bovine tuberculosis.
5 ecies and an important wildlife reservoir of bovine tuberculosis.
6 seases such chronic wasting disease (CWD) or bovine tuberculosis.
7 from lymph nodes and hence the diagnosis of bovine tuberculosis.
8 ed to cattle with gross pathology typical of bovine tuberculosis.
9 d to maintain control measures for human and bovine tuberculosis.
10 vis developed pulmonary pathology typical of bovine tuberculosis.
11 icant contribution to the immune response in bovine tuberculosis.
12 igh-throughput molecular diagnostic test for bovine tuberculosis.
13 ting the presence of this type 2 cytokine in bovine tuberculosis.
14 identified as major seroreactive antigens in bovine tuberculosis.
15 y old and allied with M. bovis, the cause of bovine tuberculosis.
16 ium bovis (M. bovis), the causative agent of bovine tuberculosis.
17 A well-known exemplar of this problem is bovine Tuberculosis, a disease found in British and Iris
18 or successful spread of virulent isolates of bovine tuberculosis among animals and to establish genot
19 e developed a multiplex serological test for bovine tuberculosis and here we provide an estimate of t
21 our understanding of the immunopathology of bovine tuberculosis and to produce more sensitive and sp
22 nding of the humoral immune responses during bovine tuberculosis and, in particular, identification o
23 the classical zoonotic pathogen and cause of bovine tuberculosis, and M. orygis, a recently recognize
24 apid and specific laboratory confirmation of bovine tuberculosis, and this is the first report of the
25 sion of Mycobacterium bovis [causal agent of bovine tuberculosis] between cattle and badgers (Meles m
26 ted the effects of anthelmintic treatment on bovine tuberculosis (BTB) acquisition, mortality after i
28 adgers (Meles meles) naturally infected with bovine tuberculosis (bTB) at Woodchester Park in Glouces
30 Kingdom, despite decades of control efforts, bovine tuberculosis (bTB) has not been controlled and cu
31 ritain (GB) due to the suspected presence of bovine tuberculosis (bTB) has progressively increased ov
34 e largest molecular epidemiological study of Bovine Tuberculosis (bTB) in a sub-Saharan African count
37 r to better understand the spatial spread of bovine tuberculosis (bTB) in Wales, an All Wales Badgers
49 cant social and economic loss as a result of bovine tuberculosis (bTB) presents a continuous challeng
50 d mammal natural resistance to worms affects bovine tuberculosis (BTB) severity independently of acti
52 host systems is difficult, as exemplified in bovine tuberculosis (bTB) systems, but is crucial for co
54 ck, the dominant species is M. bovis causing bovine tuberculosis (bTB), a disease of global zoonotic
56 ught to be the primary wildlife reservoir of bovine tuberculosis (bTB), an endemic disease in cattle.
58 tests (TST), the primary diagnostic tool for bovine tuberculosis (bTB), cross-react with BCG vaccine.
61 er is recognised as a wildlife reservoir for bovine tuberculosis (bTB); the control of which is compl
66 tibilities to infectious diseases, including bovine tuberculosis, East Coast fever, and tropical thei
68 on with harvest, in reducing and eliminating bovine tuberculosis from deer populations in Michigan, w
69 vis infection, which is a prominent cause of bovine tuberculosis, has been confirmed by mycobacterial
70 Mycobacterium bovis, the causative agent of bovine tuberculosis, has been increasing in UK cattle he
72 ium bovis, the causative agents of human and bovine tuberculosis, have been reported to express a ran
73 e valuable insights into the epidemiology of bovine tuberculosis in badger populations and inform dis
75 should be useful in modeling the dynamics of bovine tuberculosis in cattle and in assessing the risk
76 bovis pathogen, BCG, is not used to control bovine tuberculosis in cattle at present, due to its var
77 nt and our understanding of the pathology of bovine tuberculosis in cattle would be greatly facilitat
78 nt and the understanding of the pathology of bovine tuberculosis in cattle would be greatly facilitat
81 itting the model to the core endemic area of bovine tuberculosis in Michigan, USA, we identified feas
82 pite a recent resurgence in the incidence of bovine tuberculosis in UK cattle herds, no associated ri
84 Mycobacterium bovis, the causative agent of bovine tuberculosis, in cattle herds in the United Kingd
85 We develop this to predict the occurrence of bovine tuberculosis incidents in cattle herds, exploitin
90 tant reassessment, especially in areas where bovine tuberculosis is endemic and where people live in
91 related to the ecology and pathogenicity of bovine tuberculosis is scarce, especially in developing
93 burden of Mycobacterium bovis, the cause of bovine tuberculosis, might be underestimated in human be
95 lied our approach to epidemiological data of bovine tuberculosis outbreaks in England and investigate
98 odel was demonstrated through application to bovine tuberculosis surveillance data from Northern and
100 outine surveillance in countries endemic for bovine tuberculosis (TB) and limited laboratory support
102 ITT and CITT) are official in vivo tests for bovine tuberculosis (TB) diagnosis using bovine and avia
105 e the association between badger culling and bovine tuberculosis (TB) incidents in cattle herds in th
109 ycobacterium bovis is the causative agent of bovine tuberculosis (TB), and it has the potential to in
115 nts IL-4delta2 and IL-4delta3 in cattle with bovine tuberculosis, using quantitative real-time revers
116 fied protein derivatives in the detection of bovine tuberculosis when the antigens are used in blood-
117 roles for the cytokines IL-17A and IL-22 in bovine tuberculosis, where they show potential as both p
118 ge-structured disease transmission model for bovine tuberculosis with integrated disease management.